Financials
- Market Capitalization 758.13 M
- Employee 29
- Founded 2018
- CEO N/A
- Website www.climbbio.com
- Headquarter Delaware, United States
- FIGI BBG00ZNKL0K6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.9
Relación precio/flujo de caja
-1 589.13
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2638 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 41.17 USD | -0.31% | -0.17% | +22.75% | +36.64% | 761.73 M USD | ||
| 2640 | OMER Omeros Corporation - Common Stock | 10.50 USD | +4.90% | +2.14% | +12.42% | +189.26% | 759.94 M USD | ||
| 2646 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.61 USD | -1.68% | +0.13% | -22.35% | -17.37% | 755.70 M USD | ||
| 2677 | AURA Aura Biosciences, Inc. - Common Stock | 7.00 USD | 0.00% | -0.43% | +9.03% | +6.71% | 723.71 M USD |